Russell Investments Group
KYTX icon

Russell Investments Group’s Kyverna Therapeutics KYTX Stock Holding History

Russell Investments Group’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3K Hold
1,313
– – ﹤0.01% 3770
2025
Q4 		$12.3K Hold
1,313
– – ﹤0.01% 3745
2025
Q3 		$7.88K Hold
1,313
– – ﹤0.01% 3834
2025
Q2 		$4.03K Sell
1,313
-4,901
-79% -$12.1K ﹤0.01% 3493
2025
Q1 		$12K Buy
6,214
+4,750
+324% +$14K ﹤0.01% 3210
2024
Q4 		$5.47K Buy
+1,464
New +$7.01K ﹤0.01% 3262

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Russell Investments Group's KYTX Position: Q1 2026 in Review

Russell Investments Group held its Kyverna Therapeutics (KYTX) position steady in Q1 2026 at 1,313 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Russell Investments Group first reported a position in KYTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.3K in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Russell Investments Group held 1,313 shares of Kyverna Therapeutics worth $11.3K as of Q1 2026.
  • Russell Investments Group left its Kyverna Therapeutics share count unchanged in Q1 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3770 holding.
  • Russell Investments Group first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Russell Investments Group's Kyverna Therapeutics position peaked at $12.3K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.